Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 371-382

  Matsuno, Fumihiko ^a   Haruta, Yuro ^a   Kondo, Masao ^a   Tsai, Hilda ^a   Barcos, Maurice ^a   Seon, Ben K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL STRAIN MCF 7; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SOLID TUMOR; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CROSS REACTIONS; ENDOTHELIUM, VASCULAR; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTOXINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; RICIN; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032971818     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
2. Folkman, J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg., 175: 409-416, 1972.
3. Auerbach, W., and Auerbach, R. Angiogenesis inhibition: a review. Pharmacol. Ther., 63: 265-311, 1994.
4. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
5. Bicknell, R., and Harris, A. L. Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. Semin. Cancer Biol., 3: 399-407, 1992.
6. Denekamp, J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol., 66: 181-196, 1993.
7. Thorpe, P. E., and Burrows, F. J. Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res. Treat., 36: 237-251, 1995.
8. Engerman, R. L., Pfaffenbach, D., and Davis, M. D. Cell turnover of capillaries. Lab. Invest., 17: 738-743, 1967.
9. Risau, W. Differentiation of endothelium. FASEB J., 9: 926-933, 1995.
10. Haruta, Y., and Seon, B. K. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6. Proc. Natl. Acad. Sci. USA, 83: 7898-7902, 1986.
11. Matsuzaki, H., Haruta, Y., and Seon, B. K. Effect of induced transformation of human leukemia cells on the expression of GP160, a novel human leukemia-associated cell surface glycoprotein. Fed. Proc., 46: 1056, 1987.
12. Gougos, A., and Letarte, M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J. Immunol., 141: 1925-1933, 1988.
13. Gougos, A., and Letarte, M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem., 265: 8361-8364, 1990.
14. Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabéu, C., Massagué, J., and Letarte, M. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem., 267: 19027-19030, 1992.
15. Bellón, T., Corbí, A., Lastres, P., Calés, C., Cebrián, M., Vera, S., Cheifetz, S., Massagué, J., Letarte, M., and Bernabéu, C. Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions. Eur. J. Immunol., 23: 2340-2345, 1993.
16. Kishimoto, T., Kikutani, H., Kr. von dem Borne, A. E. G., Goyert, S., Mason, D., Miyasaka, M., Moretta, L., Okumura, K., Shaw, S., Springer, T. A., Sugamura, K., and Zola, H. (eds.). Leukocyte Typing VI: White Cell Differentiation Antigens, pp. 693-790. New York: Garland Publishing, Inc., 1998.
17. Burrows, F. J., Derbyshire, E. J., Tazzari, P. L., Amlot, P., Gazdar, A. F., King, S. W., Letarte, M., Vitetta, E. S., and Thorpe, P. E. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin. Cancer Res., 1: 1623-1634, 1995.
18. Seon, B. K., Matsuno, F., Haruta, Y., Kondo, M., and Barcos, M. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin. Cancer Res., 3: 1031-1044, 1997.
19. Wang, J. M., Kumar, S., Pye, D., van Agthoven, A. J., Krupinski, J., and Hunter, R. D. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int. J. Cancer, 54: 363-370, 1993.
20. Seon, B. K., Matsuno, F., Haruta, Y., Barcos, M., and Spaulding, B. CD 105 Workshop: Immunohistochemical detection of CD105 in the vascular endothelium of human malignant and non-malignant tissues. In: T. Kishimoto, H. Kikutani, A. E. G. Kr. von dem Borne, S. Goyert., D. Mason, M. Miyasaka, L. Moretta, K. Okumura, S. Shaw, T. A. Springer, K. Sugamura, and H. Zola (eds.), Leukocyte Typing VI: White Cell Differentiation Antigens, pp. 709-710. New York: Garland Publishing, Inc., 1998.
21. Dighiero, G. Autoreactive B-cell repertoire. In: C. Bona and A. Kaushik (eds.), Molecular Immunobiology of Self Reactivity, pp. 39-60. New York: Marcel Dekker, 1991.
22. O'Connell, K. A., and Edidin, M. A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. J. Immunol., 144: 521-525, 1990.
23. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
24. Kawata, A., Yoshida, M., Okazaki, M., Yokota, S., Barcos, M., and Seon, B. K. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody. Cancer Res., 54: 2688-2694, 1994.
25. Seon, B. K., Negoro, S., and Barcos, M. P. Monoclonal antibody that defines a unique human T cell leukemia antigen. Proc. Natl. Acad. Sci. USA, 80: 845-849, 1983.
26. Matsuzaki, H., Haruta, Y., Fukukawa, T., Barcos, M. P., and Seon, B. K. Unique epitopes of common acute lymphoblastic leukemia antigen detected by new monoclonal antibodies. Cancer Res., 47: 2160-2166, 1987.
27. Thorpe, P. E., Wallace, P. M., Knowies, P. P., Relf, M. G., Brown, A. N. F., Watson, G. J., Knyba, R. E., Wawrzynczak, E. J., and Blakey, D. C. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res., 47: 5924-5931, 1987.
28. Rokhlin, O. W., Cohen, M. B., Kubagawa, H., Letarte, M., and Cooper, M. D. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J. Immunol., 154: 4456-4465, 1995.
29. Seon, B. K. Specific killing of human T leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies. Cancer Res., 44: 259-264, 1984.
30. Kerbel, R. S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. BioEssays, 13: 31-36, 1991.
31. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
32. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am., 271: 58-65, 1994.
33. Dvorak, H. F., Nagy, J. A., and Dvorak, A. M. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells, 3: 77-85, 1991.
34. Hawkins, M. J. Clinical trials of antiangiogenic agents. Curr. Opin. Oncol., 7: 90-93, 1995.
35. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
36. Nelson, N. J. Inhibitors of angiogenesis enter Phase III testing. J. Natl. Cancer Inst., 90: 960-963, 1998.
37. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
38. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
39. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst., 87: 581-586, 1995.
40. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
41. Olson, T. A., Mohanraj, D., Roy, S., and Ramakrishnan, S. Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int. J. Cancer, 73: 865-870, 1997.
42. Arap, W., Pasqualini, R., and Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (Washington DC), 279: 377-380, 1998.
43. Burrows, F. J., and Thorpe, P. E. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature Proc. Natl. Acad. Sc. USA, 90: 8996-9000, 1993.
44. Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., and Thorpe, P. E. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (Washington DC), 275: 547-550, 1997.
45. 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest., 96: 1815-1822, 1995.
46. Brekken, R. A., Huang, X., King, S. W., and Thorpe, P. E. Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res., 58: 1952-1959, 1998.
47. Thrush, G. R., Lark, L. R., Clinchy, B. C., and Vitetta, E. S. Immunotoxins. An update. Annu. Rev. Immunol., 14: 49-71, 1996.
48. Endo, Y., and Tsurugi, K. RNA N-glycosidase activity of ricin A-chain. J. Biol. Chem., 262: 8128-8130, 1987.
49. Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., Barnathan, E. S., McCrae, K. R., Hug, B. A., Schmidt, A-M., and Stern, D. M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91: 3527-3561, 1998.